ClinicalTrials HQ

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Recruiting · NCT06998407 · Registry updated 2026-08-10
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid TumorsHR+, HER2-, Advanced Breast Cancer; HR+/HER2- Breast CancerRecruitingPhase 1 / Phase 22026-08-10NCT06998407

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Avenzo Therapeutics, Inc.4

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Avenzo Therapeutics Recruiting SiteBostonUnited States2
Avenzo Therapeutics Recruiting SiteSarasotaUnited States3
Avenzo Therapeutics Recruiting SiteFort WorthUnited States1
Avenzo Therapeutics Recruiting SiteNashvilleUnited States2
Avenzo Therapeutics Recruiting SiteSan AntonioUnited States2
Avenzo Therapeutics Recruiting SiteTampaUnited States4
Avenzo Therapeutics Recruiting SiteNew YorkUnited States2
Avenzo Therapeutics Recruiting SiteHoustonUnited States2
Avenzo Therapeutics Recruiting SiteFairfaxUnited States3
Avenzo Therapeutics Recruiting SiteColumbusUnited States1
Avenzo Therapeutics Recruiting SiteLos AngelesUnited States2
Avenzo Therapeutics Recruiting SiteLos AngelesUnited States1
Avenzo Therapeutics Recruiting SiteClevelandUnited States3
Avenzo Therapeutics Recruiting SiteOrlandoUnited States3
Avenzo Therapeutics Recruiting SiteNew HavenUnited States2
Avenzo Therapeutics Recruiting SiteSeattleUnited States2